Cargando…
Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomized controlled trial
BACKGROUND: N-acetylcysteine is a classic mucolytic agent. This study aimed to investigate the efficacy of N-acetylcysteine on reducing the risk of exacerbations in bronchiectasis patients. METHODS: A prospective, randomized, controlled trial was conducted between April 1, 2014 and December 31, 2016...
Autores principales: | Qi, Qian, Ailiyaer, Yirepanjaing, Liu, Ruijuan, Zhang, Yan, Li, Caiyu, Liu, Mingtao, Wang, Xiuxiu, Jing, Lijun, Li, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458826/ https://www.ncbi.nlm.nih.gov/pubmed/30975143 http://dx.doi.org/10.1186/s12931-019-1042-x |
Ejemplares similares
-
Be'ne gub'yelhe /
por: Molina Cruz, René
Publicado: (1991) -
Annual Report of the BENE Collaboration
por: Palladino, V, et al.
Publicado: (2005) -
Annual Report of the BENE Collaboration
por: Palladino, V, et al.
Publicado: (2006) -
Annual Report of the BENE Collaboration
por: Palladino, V, et al.
Publicado: (2007) -
Annual Report of the BENE Collaboration
por: Palladino, V, et al.
Publicado: (2008)